Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Outsourcing-Pharma" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Outsourcing-Pharma for you to read. Along with our medical data and news we also list Outsourcing-Pharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Outsourcing-Pharma Companies for you to search.
Quanticate is bolstering its pharmacovigilance services with a recent addition to its risk management platform.
The practice of incorporating the voice of the patient into clinical development has gained significant traction over the past decade, and rightfully so.
With offices in Philadelphia and Boston, Vynamicâs London office â co-located with STEM Healthcare â is the companyâs first outside the US as it looks to support existing and new clients globally.
Studies are underway as the provider of genetically engineered rodent model solutions completes its most recent trip to the International Space Station.
The industry group recently announced its first technology standard, which addresses operational data exchange in an aim to improve information sharing between sponsors and CROs.
The Almac Group is doubling its Edinburgh-based footprint to help meet the growing demand for personalized cancer vaccines production.
PinneyAssociates and NMS Labs will plan, conduct, and analyze in vitro laboratory testing of pharmaceutical formulations to evaluate any abuse-deterrent properties, says CMO.
Unchained Labsâ new facility will support its North American customers with specialized services in particle identification and visibility.
August Research is adding clinical trial operations in Georgia and Moldova, expanding the CROâs reach in Central and Eastern Europe â a less developed market with âfewer competitive trials and lower costs,â says CEO.
LakePharma opens a GMP biorepository facility to assist clients with biomanufacturing and long-term material storage.
The All of Us research program is expanding its data collection abilities via Fitbit â a move that further demonstrates the industryâs increasing adoption of a BYOD approach, says Thread executive.
Aurelia Bioscience is now offering kinase compound profiling services using Promegaâs NanoBRET technology.
RadMD is partnering with AG Mednet to provide a new âcollect and holdâ service, which will provide sponsorâs with real-time image access.
Roche has launched its new cobas pro integrated solutions to reduce manual operations in the lab â as well as new enterprise software for digital pathology.
Lonza provided development, manufacturing, and clinical packaging services for Takedaâs Alunbrig, which has received EMA marketing authorization.
Key Biologics and Cascade Regional Blood Servicesâ multi-year agreement will provide researchers with the critical raw material needed for developing cell- and gene-based therapies.
Researchers are making the case for clinical trial completion bonuses â the complete rejection of which they argue is unnecessary and problematic.
Sanofi will use AbSciâs platform to further optimize two of its in-house proteins â and will partner with other companies to accelerate timelines and reduce costs.
Sanofi will use AbSciâs platform to further discovery of its in-house proteins â and will partner with other companies to accelerate timelines and reduce costs.
Strategikon Pharma releases new modules for its Clinical Maestro software suite â another step in the companyâs journey to harmonize sponsor and CRO operations, with further updates slated for later this year, says CCO.
ClinOne uses text messaging and automated reminders to help ensure medication adherence in clinical trials with its new service, DoseMonitor.
Caprion Biosciences will provide mass cytometry services to expand its offerings as a specialty CRO after its acquisition of Primity Bio.
Genetic discoveries have taken place in narrow population groups, say researchers, who for the first time, reveal that such studies are concentrated in a handful of countries â and conducted by a âtight-knit group of researchers.â
AstraZeneca and Aptamer Group will collaborate to leverage Aptamerâs platform for targeted delivery of oligonucelotides to the kidney for therapeutic development.
Pressure BioSciences has launched a commercial biopharmaceutical contract service business after acquiring a protein therapeutics platform that it says reduces challenges and manufacturing costs of the growing drug market.